EUVIMEDEUVIMED entdecken
Crossref

Naringin dihydrochalcone alleviates sepsis-induced acute lung injury via improving gut microbial homeostasis and activating GPR18 receptor

Siqi He, Yuzhen Zhuo, Lingzhi Cui, Sijia Zhang, Zhengwei Tu, Mukuo Wang, Xinyue Lv, Lixiu Ge, Jianping Lin, Lei Yang, Ximo Wang

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Siqi He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Tianjin Medical University, Tianjin 300270, China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Gastrointestinal Microbiome, Acute Lung Injury, Sepsis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Inner Mongolia Autonomous Region, Natural Science Foundation of Tianjin Municipal Science and Technology Commission, Nanjing Municipal Health Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) is a life-threatening disease characterized by severe lung inflammation and intestinal microbiota disorder. The GPR18 receptor has been demonstrated to be a potential therapeutic target against ALI. Extracting Naringin dihydrochalcone (NDC) from the life-sustaining orange peel is known for its diverse anti-inflammatory properties, yet the specific action target remains uncertain. In the present study, we identified NDC as a potential agonist of the GPR18 receptor using virtual screening and investigated the pharmacological effects of NDC on sepsis-induced acute lung injury in rats and explored underlying mechanisms. In in vivo experiments, CLP-induced ALI model was established by cecum puncture and treated with NDC gavage one hour prior to drug administration, lung histopathology and inflammatory cytokines were evaluated, and feces were subjected to 16s rRNA sequencing and untargeted metabolomics analysis. In in vitro experiments, the anti-inflammatory properties were exerted by evaluating NDC targeting the GPR18 receptor to inhibit lipopolysaccharide (LPS)-induced secretion of TNF-α, IL-6, IL-1β and activation of inflammatory signaling pathways in MH-S cells. Our findings showed that NDC significantly ameliorated lung damage and pro-inflammatory cytokine levels (TNF-α, IL-6, IL-1β) in both cells and lung tissues via inhibiting the activation of STAT3, NF-κB, and NLRP3 inflammatory signaling pathways through GRP18 receptor activation. In addition, NDC can also partly reverse the imbalance of gut microbiota composition caused by CLP via increasing the proportion of Firmicutes/Bacteroidetes and Lactobacillus and decreasing the relative abundance of Proteobacteria. Meanwhile, the fecal metabolites in the NDC treatment group also significantly were changed, including decreased secretion of Phenylalanin, Glycine, and bile secretion, and increased secretion of Lysine. In conclusion, these findings suggest that NDC can alleviate sepsis-induced ALI via improving gut microbial homeostasis and metabolism and mitigate inflammation via activating GPR18 receptor. In conclusion, the results indicate that NDC, derived from the typical orange peel of food, could significantly contribute to development by enhancing intestinal microbial balance and metabolic processes, and reducing inflammation by activating the GPR18 receptor, thus mitigating sepsis-induced ALI and expanding the range of functional foods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledGastrointestinal MicrobiomeAcute Lung InjurySepsisCytokinesChalconesAnti-Inflammatory AgentsAnimalsMaleRatsRats, Sprague-DawleyHomeostasisCell LineLungDisease Models, AnimalLipopolysaccharidesHumansFlavanones

Stichwörter der Autor:innen

Acute lung injury (ALI)GPR18 receptorGut microbiotaMetabolomicsNDC

Substanzen

Receptors, G-Protein-CoupledCytokinesChalconesAnti-Inflammatory AgentsnaringinGpbar1 protein, ratLipopolysaccharidesFlavanones

Autor:innen und Institutionen

  • Graduate School, Tianjin Medical University, Tianjin 300270, China.
  • Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Tianjin NanKai Hospital Tianjin Medical University, Tianjin 300100, China.
  • College of Pharmacy, Nankai University, Tianjin 300071, China.
  • College of Pharmacy, Nankai University, Tianjin 300071, China. Electronic address: jianpinglin@nankai.edu.cn.
  • Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Tianjin NanKai Hospital Tianjin Medical University, Tianjin 300100, China. Electronic address: nkyanglei@126.com.
  • Graduate School, Tianjin Medical University, Tianjin 300270, China; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute…

Förderung

  • Natural Science Foundation of Inner Mongolia Autonomous Region
  • Natural Science Foundation of Tianjin Municipal Science and Technology Commission
  • Nanjing Municipal Health Bureau
  • National Natural Science Foundation of China

Zitieren

APA

He, S., Zhuo, Y., Cui, L., Zhang, S., Tu, Z., Wang, M., Lv, X., Ge, L., Lin, J., Yang, L., & Wang, X. (2024). Naringin dihydrochalcone alleviates sepsis-induced acute lung injury via improving gut microbial homeostasis and activating GPR18 receptor. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112418

Vancouver

He S, Zhuo Y, Cui L, Zhang S, Tu Z, Wang M, et al. Naringin dihydrochalcone alleviates sepsis-induced acute lung injury via improving gut microbial homeostasis and activating GPR18 receptor. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112418

BibTeX
@article{He2024,
  author = {He, Siqi and Zhuo, Yuzhen and Cui, Lingzhi and Zhang, Sijia and Tu, Zhengwei and Wang, Mukuo and Lv, Xinyue and Ge, Lixiu and Lin, Jianping and Yang, Lei and Wang, Ximo},
  title = {Naringin dihydrochalcone alleviates sepsis-induced acute lung injury via improving gut microbial homeostasis and activating GPR18 receptor},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112418}
}
Kostenlos starten →